Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1975 Mar 1;141(3):697-702.
doi: 10.1084/jem.141.3.697.

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

P W Askenase, B J Hayden, R K Gershon
Comparative Study

Augmentation of delayed-type hypersensitivity by doses of cyclophosphamide which do not affect antibody responses

P W Askenase et al. J Exp Med. .

Abstract

Mice immunized with more SRBC than are required to produce optimal delayed-type hypersensitivity reactions, developed good antibody responses and poor delayed foot pad reactions. Cyclophosphamide treatment in low doses (20 mg/kg) before immunization, augmented the delayed-type hypersensitivity without affecting antibody responses. Cyclophosphamide did not augment delayed responses to optimal doses of SRBC (0.01%), but did augment the delayed hypersensitivity response of mice immunized with a suboptimal antigen dose (0.001%); which produced no detectable antibody response with or without cyclophosphamide pretreatment. These results suggest that antibody feedback is not the sole regulator of delayed reactions; the possibility that suppressor T cells may also be involved is discussed.

PubMed Disclaimer

References

    1. Immunology. 1959 Jan;2(1):53-63 - PubMed
    1. Immunol Commun. 1972;1(3):289-99 - PubMed
    1. Nature. 1974 Jun 14;249(458):654-6 - PubMed
    1. J Exp Med. 1974 Mar 1;139(3):543-59 - PubMed
    1. J Exp Med. 1974 Mar 1;139(3):528-42 - PubMed

Publication types

Substances